{"id":13290,"date":"2016-08-26T00:00:00","date_gmt":"2016-08-26T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/predict2010\/"},"modified":"2019-03-01T12:12:24","modified_gmt":"2019-03-01T12:12:24","slug":"predict2010","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/surveys\/predict2010\/","title":{"rendered":"Predicting the Future of the Drug Industry: 2012 and Beyond"},"content":{"rendered":"

Predicting the Future of the Drug Industry: 2012 and Beyond \"Predicting<\/a> <\/p>\n

This survey solicits your opinion regarding what lies ahead for the pharmaceutical industry in the next 5 to 8 years. Take the survey now (click here<\/a>) and see a summary of the results after you complete the survey. It only takes about 5 to 10 minutes.<\/p>\n<\/p>\n

See Resources & Further Reading below…<\/a><\/p>\n

Background<\/b> Now is a good time to look into our crystal balls and predict the future scenarios for the pharmaceutical industry. Let’s take a slightly long-term view and predict how likely the following will be in the next several (ie, 2012 to 2019): <\/p>\n

    \n
  1. New follow-on biologics legislation in the U.S. will increase competition from generic equivalents and eventually decrease brand profits<\/li>\n
  2. Broadcast (ie, TV) Direct-to-Consumer (DTC) drug promotion will be banned or sharply curtailed by law in the U.S.<\/li>\n
  3. The European Union will finally allow Direct-to-Consumer (DTC) advertising to its citizens<\/li>\n
  4. Internet-based drug promotion (including search engine marketing) will overtake TV-based DTC in the U.S. in terms of dollars spent<\/li>\n
  5. Due to decreasing effectiveness of traditional physician detailing and rise of non-personal detailing, the role of traditional sales representative will become obsolete<\/li>\n
  6. New healthcare reform legislation will dramatically increase the sales of drugs in the U.S.<\/li>\n
  7. Extensive outcomes data available to payers and comparative effectiveness research will force the industry much further down the path of pay-for-performance (ie, adopt a more flexible approach to pricing)<\/li>\n
  8. Patients will become even more influential and empowered in making healthcare decisions as they are forced to pay a larger share of costs and\/or have access to health information from a variety of sources<\/li>\n
  9. Despite lack of innovative new drugs and\/or generic competition, sales of brand drugs worldwide will show a sharp increase due to increased demand in emerging markets (eg, China)<\/li>\n
  10. More efficient targeting of drugs and marketing to specific patient populations will greatly increase effectiveness and decrease side effects of drugs<\/li>\n
  11. Social media marketing will become a significant part (>10%) of the pharmaceutical marketing mix<\/li>\n
  12. The next BIG opportunity for targeted marketing to patients and physicians is mobile apps on “smart phones”<\/li>\n
  13. Pharmaceutical and biotech companies will continue to increase their outsourcing of clinical trials and related drug development. Outsourcing will account for more than 50% of R&D spending by 2019.<\/li>\n<\/ol>\n

    It’s a lot to think about, we know. As a “pre-Thank You” for taking this survey (click here<\/a>), enjoy the FREE reprints and discounted special supplements covering many of the issues involved in these scenarios below. After taking the survey, you will be able to see a summary of the results. <\/p>\n<\/p>\n

    Resources & Further Reading:<\/b><\/a> <\/p>\n

    The following Pharma Marketing News<\/b><\/i> articles\/supplements are available as background for the topics listed: <\/p>\n<\/p>\n

      \n
    1. Comparative Effectiveness Research<\/b>:\n